Kidney Transplant From Hepatitis C Infected Donors ‘Safe & Effective’

In order to confirm the safety and functional efficacy of HCV infected kidneys, the study team comprising Vishnu S. Potluri, MD, MPH, Peter P. Reese, MD, MSCE and David S. Goldberg, MD, MSCE (University of Pennsylvania) and other team members looked at the national transplant registry data on the use of HCV-infected kidneys from 2015 to 2019.

Advertisement

Using the data, they compared outcomes in recipients who received uninfected kidneys to those who received HCV infected kidneys. The results are as follows: 

• The team designed the study to create almost similarly matched sets, in which the donors and recipients had almost similar parameters qualities such as age, weight or history of hypertension, differing only in HCV status
• The team then used the Chronic Kidney Disease Epidemiology Collaboration equation, a widely used mathematical calculation to estimate the glomerular filtration rate (eGFR) of each recipient (GFR is a measure of kidney function and the lower the value, the poorer the kidney function. Values below 60 are considered abnormal)
• One year post-transplant, the study team found that recipients who received HCV-infected kidneys had an eGFR of 66.3 compared to an eGFR of 67.1 in recipients of uninfected kidneys
• A heartening finding was that the team found both transplant centers, as well as patients,  were willing to accept the organs
• From 11 transplant centers in 2015 using HCV infected kidneys, the numbers surged to 39 centers during the first three months of 2019

The findings of the study suggest that using good quality kidneys from HCV-infected donors can be safe and effective and found to function as well as uninfected kidneys even one-year post-transplant.

"Our study showed that transplants with HCV- infected kidneys are now routinely performed at many centers, and they are functioning well at one year after transplant," said Dr. Reese. Added Dr Potluri, "These findings represent a small, but important victory, in the effort to make every organ donation count."

Scope of Study and Encouraging Trends

• HCV kidneys that were earlier discarded will now be available and benefit more patients with end-stage kidney disease (ESRD)
• With effective antiviral treatments available, transplant followed by antiviral therapy provides very good outcomes for kidney transplant recipients
• Both patients and transplant centers are more open to accepting the organs following the findings of the national study
• The number of transplant centers using HCV-infected kidneys has more than tripled from just 11 in 2015 to nearly 40 in the early part of 2019
• Criteria for accepting or rejecting kidneys should be reviewed and gaps addressed so that more patients benefit

In summary, the findings that HCV infected kidneys are safe and function equally well as uninfected kidneys should lead to more centers choosing to use good quality HCV infected kidneys ensuring more patients with kidney failure are benefited as well as improved patient outcomes.

Reference :

1. National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys - (https://jasn.asnjournals.org/content/early/2019/09/12/ASN.2019050462)

Source: Medindia